Post-test

Economic Value for Early Treatment in MS

Post Test

A score of 70% must be achieved to receive continuing education credits.

1.

Multiple Sclerosis is characterized by chronic inflammation in the central nervous system.
True
False

2.

Which of the following are symptoms of MS?
a. Fatigue
b. Depression
c. Pain
d. All of the above

3.

What are the key aspects of treatment?
a. Disease modification
b. Treatment of associated systems
c. Both A & B
d. None of the above

4.

Increasing MS disability will decrease probability of unemployment.
True
False

5.

A clinical relapse is always accompanied by changes in the patient’s physical exam.
True
False

6.

What is FDA-Approved for maintenance treatment of MS?
a. Mitoxantrone
b. Natalizumab
c. Both A & B
d. None of the above

7

The acute treatment for acute relapses include:
a. Corticosteriods
b. ACTH
c. IVIG
d. All of the above

8

In a glatiramer acetate trial the patient visits were monitored every _____ months over ____ years.
a. 3, 5
b. 6, 10
c. 9, 15
d. None of the above

9

Minimizing disability decreases only direct costs of MS care.
True
False

10

Early treatment of MS is cost effective over the life of an individual with MS.
True
False

Activity Evaluation

Please rate this activity on the following scale:
4 - Excellent 3 - Good 2 - Fair 1 - Poor

Due to the content of this activity, I will change my practice patterns by:

	Providing appropriate education to patients
	Explain the different treatment options
	Be aware of the symptoms of MS
	My practice patterns will not change
	Other Specify:

Continuing education implies quality improvement in behavior. As part of our quality improvement process, NAMCP/AAMCN will contact you 6 months from your post test submission to monitor change.